A drug that targets the deadliest form of breast cancer was administered to 16 women in three separate doses in a trial conducted at the Cleveland Clinic with funding from the Pentagon. The trial found that the drug elicits no side effects and triggered an immune response in 75% of patients.
Researchers from the Cleveland Clinic have conducted the first human trials of a new drug, lepodisiran, that has the potential to eliminate a risk factor for cardiovascular disease for which there is currently no treatment.
Ohio voters approved a constitutional amendment that ensures access to abortion and other forms of reproductive health care. Ohio became the seventh state where voters decided to protect abortion access since the Supreme Court overturned Roe v. Wade in 2022.
Researchers from Monash University, Cleveland Clinic, and Eli Lilly have developed an oral drug to target a form of cholesterol that has previously been untreatable and is largely caused by genetics.
In 2006, the U.S. EPA banned the agricultural use of lindane, linked to anemia, lung cancer, and lymphoma. In 2010, it began to phase out endosulfan, which experts say may damage the liver and kidneys.
The machine dispensed more than 3,000 doses of naloxone and 10,000 drug test strips in the first year after it was installed in February 2021.
In a 7-5 vote, council members approved legislation to create a partnership between the city and a nonprofit group called RIP Medical Debt to relieve debt for eligible Toledo residents.
In the longest coral resilience experiment ever, researchers found that two coral species cope well with changing ocean conditions and could be used for reef restoration.
The U.S. Environmental Protection Agency (EPA) will clean up, strengthen nearby infrastructure, and improve nearby supporting communities in 22 identified areas of concern.
After two decades of preclinical research, human trials are set to begin on a unique preventative vaccine that is designed to target a protein commonly expressed by triple-negative breast cancers.
